Method for effectively reducing impurity content in oral solution for treating bronchial asthma
A technology for bronchial asthma and oral solution, applied in the field of medicine to achieve the effect of improving product safety
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Examples
Embodiment 1
[0015] A method for effectively reducing the content of impurities in a certain oral solution for the treatment of bronchial asthma, characterized in that: filling the ketotifen fumarate solution after dilution to a constant volume into a brown glass bottle, and placing the ketotifen fumarate solution in a brown glass bottle. Fill argon above the liquid level of the brown glass bottle, and the residual oxygen above the liquid level of the ketotifen fumarate solution in the brown glass bottle is 5%;
[0016] When the residual oxygen amount above the liquid level of the ketotifen fumarate solution was 5%, the impurity G content after 6 months of acceleration was 0.55%.
Embodiment 2
[0018] A method for effectively reducing the content of impurities in a certain oral solution for the treatment of bronchial asthma, characterized in that: filling the ketotifen fumarate solution after dilution to a constant volume into a brown glass bottle, and placing the ketotifen fumarate solution in a brown glass bottle. Argon gas is filled above the liquid level of the brown glass bottle, and the residual oxygen above the liquid level of the ketotifen fumarate solution in the brown glass bottle is 10%;
[0019] When the residual oxygen amount above the liquid level of the ketotifen fumarate solution was 10%, the impurity G content was 0.82% after 6 months of acceleration.
Embodiment 3
[0021] A method for effectively reducing the content of impurities in a certain oral solution for the treatment of bronchial asthma, characterized in that: filling the ketotifen fumarate solution after dilution to a constant volume into a brown glass bottle, and placing the ketotifen fumarate solution in a brown glass bottle. Fill argon above the liquid level of the brown glass bottle, and the residual oxygen above the liquid level of the ketotifen fumarate solution in the brown glass bottle is 15%;
[0022] When the residual oxygen amount above the liquid level of the ketotifen fumarate solution was 15%, the impurity G content was 0.94% after 6 months of acceleration.
[0023] From this, it can be known that the limit of impurity G is: not more than 1.0%. The experimental results show that when the residual oxygen content is 5%-15%, the content of impurity G after 6 months of acceleration is less than the limit of 1.0%.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com